Clinical trial
Evaluation of an Antibiotic Treatment With 14 Days of Intravenous Tobramycin Versus the Same Antibiotic Associated With 5 Days of Intravenous Tobramycin Followed by Tobramycin Aerosol for 9 Days in Cystic Fibrosis.
NCT03066453 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of an Antibiotic Treatment With 14 Days of Intravenous Tobramycin Versus the Same Antibiotic Associated With 5 Days of Intravenous Tobramycin Followed by Tobramycin Aerosol for 9 Days in Cystic Fibrosis.
- Lead sponsor
- University Hospital, Lille
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- June 13, 2017
- Completion date
- January 16, 2020
- Enrollment
- 23 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.